828 results on '"Portelius, Erik"'
Search Results
2. Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using Biomarkers
3. Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides
4. Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
5. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
6. Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury
7. Profiling amyloid‐β peptides as biomarkers for cerebral amyloid angiopathy.
8. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
9. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
10. Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta
11. Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
12. Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
13. Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics
14. Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
15. Profiling amyloid‐β peptides as diagnostic biomarkers for cerebral amyloid angiopathy
16. Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
17. The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
18. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
19. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease
20. Alzheimer's disease markers in the aged sheep (Ovis aries)
21. Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease
22. Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
23. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
24. Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
25. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
26. Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
27. Explorative and targeted neuroproteomics in Alzheimer's disease
28. Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders
29. CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers
30. Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
31. The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
32. Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21
33. Population-based blood screening for preclinical Alzheimer’s disease in a British birth cohort at age 70
34. Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ
35. Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
36. Specific mutations in the cholesterol-binding site of APP alter its processing and favor the production of shorter, less toxic Aβ peptides.
37. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid
38. Cerebral organoids: in vitro model for brain development and neurodegeneration
39. Additional file 1 of Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
40. A novel pathway for amyloid precursor protein processing
41. Altered Cerebrospinal Fluid Levels of Amyloid β and Amyloid Precursor-Like Protein 1 Peptides in Down’s Syndrome
42. Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
43. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid
44. γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
45. Amyloid‐βeta peptides in CSF and plasma discriminate cerebral amyloid angiopathy from controls
46. A novel antibody‐free mass spectrometry panel of CSF biomarkers for synaptic dysfunction
47. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
48. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression
49. A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
50. Aβ1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.